Skip to main content

Advertisement

Log in

Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis is a chronic autoimmune disorder associated with altered expression of pro- and anti-inflammatory cytokines in the affected tissues. The aim of this study was to investigate the association between promoter polymorphisms of TNFα and IL-10 gene with susceptibility, age of disease onset and disease severity in North Indian patients with rheumatoid arthritis (RA). SNPs at position −308 and −863 of TNF gene and −819/−592 and −1082 position of IL-10 gene were determined in 222 patients and 208 healthy controls using RFLP or ARMS method. Polymorphism TNF −308A was less prevalent among the patients (1.7%) than controls (4.9%; p = 0.01, OR: 0.32, 95% CI: 0.13–0.76). Among female patients, IL-10 −592A allele associated with higher baseline disease activity scores (5.77 ± 1.99) than −592C (5.57 ± 1.19; p = 0.04). Female patients carrying allele A of TNFα −863 had earlier age of onset of RA (33.99 ± 9.6 years) than those with allele C (36.15 ± 11.21 years; p = 0.043). In conclusion, allele A at TNFα −308 locus provides protection against RA in North Indian population while another TNF allele A at −863 position had weak association with earlier onset of disease in female patients. On the other hand promoter polymorphisms of IL-10 did not affect susceptibility but polymorphism at −819/−592A was associated with higher disease activity scores at baseline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kirkham BW, Lassere MN, Edmonds JP et al (2006) Synovial membrane cytokine expression is predictive of joint damage progression in Rheumatoid arthritis. Arthritis Rheum 54:1122–1131

    Article  CAS  PubMed  Google Scholar 

  2. Paramalingam SS, Thumboo J, Vasoo S et al (2007) In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis. Ann Acad Med Singap 36:96–99

    Google Scholar 

  3. Brennan FM, Maini RN, Feldmann M (1992) TNF alpha-A pivotal role in rheumatoid arthritis. Br J Rheumatol 31:293–298

    Article  CAS  PubMed  Google Scholar 

  4. Keffer J, Probert L, Cazlaris H et al (1991) Transgenic mice expressing human tumor necrosis factor: a predictive model of arthritis. EMBO J 10:4025–4031

    CAS  PubMed  Google Scholar 

  5. Elliott MJ, Maini RN, Feldmann M et al (1993) Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36:1681–1690

    Article  CAS  PubMed  Google Scholar 

  6. Persson S, Mikulowska A, Narula S et al (1996) Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 44(6):607–614

    Article  CAS  PubMed  Google Scholar 

  7. Jorgensen C, Apparailly F, Canovas F et al (1999) Systemic viral interleukin-10 gene delivery prevents cartilage invasion by human rheumatoid synovial tissue engrafted in SCID mice. Arthritis Rheum 42(4):678–685

    Article  CAS  PubMed  Google Scholar 

  8. Brennan FM (1999) IL-10 and arthritis. Rheumatology (Oxford) 38:293–297

    Article  CAS  Google Scholar 

  9. Trinchieri G (1997) Cytokines acting on or secreted by macrophages during intracellular infection. Curr Opin Immunol 9:17–23

    Article  CAS  PubMed  Google Scholar 

  10. Dickensheets H, Freeman SL, Smith M et al (1997) Interleukin 10 upregulates tumour necrosis factor type-II (p75) gene expression in endotoxin-stimulated human monocytes. Blood 90:4162–4171

    CAS  PubMed  Google Scholar 

  11. Bayley JP, Ottenhoff TH, Verweij CL (2004) Is there a future for TNF promoter polymorphisms? Genes Immun 5:315–329

    Article  CAS  PubMed  Google Scholar 

  12. Westendorp RG, Langermans JA, Huizinga TW et al (1997) Genetic influence on cytokine production and fatal meningococcal disease (published erratum appears in Lancet 1997;349:656) (see comments). Lancet 349:170–173

    Google Scholar 

  13. D’Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39:150–154

    PubMed  Google Scholar 

  14. Higuchi T, Seki N, Kamizono S et al (1998) Polymorphism of the 5′-flanking region of the human tumour necrosis factor(TNF)-alpha gene in Japanese. Tissue Antigens 51:605–612

    Article  CAS  PubMed  Google Scholar 

  15. Uglialoro AM, Turbay D, Pesavento PA et al (1998) Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 52:359–367

    Article  CAS  PubMed  Google Scholar 

  16. Brinkman BM, Giphart MJ, Verhoef A et al (1994) Tumor necrosis factor alpha-308 gene variants in relation to major histocompatibility complex alleles and Felty’s syndrome. Hum Immunol 41:259–266

    Article  CAS  PubMed  Google Scholar 

  17. Wilson AG, di Giovine FS, Blakemore AI (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1:353

    Article  CAS  PubMed  Google Scholar 

  18. Brinkman BM, Kaijzel EL, Huizinga TW et al (1995) Detection of a C insertion polymorphism within the human tumor necrosis factor alpha (TNFA) gene. Hum Genet 96:493

    Article  CAS  PubMed  Google Scholar 

  19. Hamann A, Mantzoros C, Vidal-Puig A et al (1995) Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211:833–839

    Article  CAS  PubMed  Google Scholar 

  20. Gibson AW, Edberg JC, Wu J et al (2001) Novel single nucleotide polymorphisms in the distal IL-10 promoter affects IL-10 production and enhance the risk of systemic lupus erythmatosus. J Immunol 166:3915–3922

    CAS  PubMed  Google Scholar 

  21. Lee YH, Ji JD, Song GG (2007) Tumour necrosis factor-α promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a metaanalysis. J Rheumatol 34:43–49

    CAS  PubMed  Google Scholar 

  22. Cvetkovic JT, Wallberg-Jonsson S, Stegmayr B et al (2002) Susceptibility and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-α, IL-1β IR-1Ra genes. J Rheumatol 29:212–219

    CAS  PubMed  Google Scholar 

  23. Hajeer AH, Lazarus M, Turner D et al (1998) IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 27:142–145

    Article  CAS  PubMed  Google Scholar 

  24. Huizinga TWJ, Keijsers V, Yanni G et al (2000) Are differences in interleukin 10 production associated with joint damage? Rheumatology 39:1180–1188

    Article  CAS  PubMed  Google Scholar 

  25. Anand SP, Selvaraj P, Jawahar MS et al (2007) Interleukin-12B & interleukin-10 gene polymorphisms in pulmonary tuberculosis. Indian J Med Res 126:135–138

    CAS  Google Scholar 

  26. Tegoshi H, Hasegawa G, Obayashi H et al (2002) Polymorphisms of interferon- γgene CA-repeat and interleukin-10 promoter region (−592A/C) in Japanese type 1 diabetes. Hum Immunol 63:121–128

    Article  CAS  PubMed  Google Scholar 

  27. Sinha S, Mishra SK, Sharma S et al (2008) Polymorphisms of TNF-enhancer and gene for FcγRIIa correlate with the severity of falciparum malaria in the ethnically diverse Indian population. Malar J 7:13

    Article  PubMed  Google Scholar 

  28. Perrey C, Turner S, Pravica V et al (1999) ARMS-PCR methodologies to determine IL-10, TNFα and TGF-1 gene polymorphisms. Transpl Immunol 7:127–128

    Article  CAS  PubMed  Google Scholar 

  29. Coakley G, Mok CC, Hajeer AH et al (1998) Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty’s syndrome. Br J Rheumatol 37(9):988–991

    Article  CAS  PubMed  Google Scholar 

  30. Skoog T, van’t Hooft FM, Kallin B et al (1999) A common functional polymorphism (C → A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF- α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 8:1443–1449

    Article  CAS  PubMed  Google Scholar 

  31. Mok CC, Lanchbury JS, Wai Chan D et al (1998) Interleukin-10 promoter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41:1090–1095

    Article  CAS  PubMed  Google Scholar 

  32. Van Gestel AM, Haagsma CJ, Van Riel PLCM (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850

    Article  CAS  PubMed  Google Scholar 

  33. Fonseca EJ, Cavaleiro J, Teles J et al (2007) Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumour necrosis factor-alpha gene promoter. Arthritis Res Ther 9:R37

    Article  PubMed  Google Scholar 

  34. Sharma S, Sharma A, Kumar S et al (2006) Association of TNF haplotypes with asthma, serum IgE levels, and correlation with serum TNF-α levels. Am J Respir Cell Mol Biol 35:488–495

    Article  CAS  PubMed  Google Scholar 

  35. Brinkman BM, Huizinga TW, Kurban SS et al (1997) Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 36:516–521

    Article  CAS  PubMed  Google Scholar 

  36. Seki N, Kamizono S, Yamada A et al (1999) Polymorphisms in the 5′-flanking region of tumour necrosis factor-alpha gene in patients with rheumatoid arthritis. Tissue Antigens 54:194–197

    Article  CAS  PubMed  Google Scholar 

  37. Yen JH, Chen CJ, Tsai WC et al (2001) Tumor necrosis factor promoter polymorphisms in patients with rheumatoid arthritis in Taiwan. J Rheumatol 28:1788–1792

    CAS  PubMed  Google Scholar 

  38. Maury CP, Liljeström M, Laiho K et al (2003) Tumor necrosis factor α, its soluble receptor I and −308 gene promoter polymorphism in patient with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis Rheum 48:3068–3076

    Article  CAS  PubMed  Google Scholar 

  39. Jaini R, Kaur G, Mehra NK (2002) Heterogeneity of HLA-DRB1*04 and its associated haplotypes in the North Indian population. Hum Immunol 63(1):24–29

    Article  CAS  PubMed  Google Scholar 

  40. Agrawal C, Raghav SK, Gupta B et al (2005) Tumour necrosis factor-alpha microsatellite polymorphism association with rheumatoid arthritis in Indian patients. Arch Med Res 36:555–559

    Article  CAS  PubMed  Google Scholar 

  41. Okamoto K, Makino S, Yoshikawa Y et al (2003) Identification of I kappa BL as the second major histocompatibility complex linked susceptibility locus for rheumatoid arthritis. Am J Hum Genet 72:303–312

    Article  CAS  PubMed  Google Scholar 

  42. Harney SMJ, Vilarino-Guell C, Adamopoulos IE et al (2008) Fine mapping of the MHC class III region demonstrates association of AIF1 and rheumatoid arthritis. Rheumatology 47:1761–1767

    Article  CAS  PubMed  Google Scholar 

  43. Hee CS, Gun SC, Naidu R et al (2007) Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Mod Rheumatol 17(5):429–435

    Article  CAS  PubMed  Google Scholar 

  44. Moreno OM, González CI, Saaibi DL et al (2007) Polymorphisms of IL-10 gene promoter and rheumatoid arthritis in a Colombian population. Biomedica 27:56–65

    PubMed  Google Scholar 

  45. Ushiyama T, Mori K, Inoue K et al (1999) Association of oestrogen receptor gene polymorphisms with age at onset of rheumatoid arthritis. Ann Rheum Dis 58:57

    Article  Google Scholar 

  46. Goemaere S, Ackerman C, Goethals K et al (1990) Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol 17(12):1620–1622

    CAS  PubMed  Google Scholar 

  47. Silman A, Kay A, Brennan P (1992) Timing of pregnancy in relation to onset of rheumatoid arthritis. Arthritis Rheum 35(2):152–155

    Article  CAS  PubMed  Google Scholar 

  48. Scola L, Crivello A, Marino V et al (2003) IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev 124(4):569–572

    Article  CAS  PubMed  Google Scholar 

  49. Udalova IA, Richardson A, Denys A et al (2000) Functional consequences of polymorphisms affecting NF-kappaB p50–50 binding to the TNF promoter region. Mol Cell Biol 2000(20):9113–9119

    Article  Google Scholar 

Download references

Acknowledgments

Deepali Gambhir is thankful to Department of Science and Technology, New Delhi, India for providing her fellowship and research grant for the project.

Conflict of interest statement

Authors DG, AL, AA, RM, SKM and SN have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deepali Gambhir.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gambhir, D., Lawrence, A., Aggarwal, A. et al. Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population. Rheumatol Int 30, 1211–1217 (2010). https://doi.org/10.1007/s00296-009-1131-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1131-0

Keywords

Navigation